Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA‐G expression correlates with malignant transformation, high inflammatory infiltration and HLA‐A1 genotype
Data up to Jan 2025
Total Citations Per Year
Abstract
References (66)
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999 • 1,168 citations
A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma
1984 • 963 citations
Solid Cancers after Bone Marrow Transplantation
1997 • 950 citations
A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells
1997 • 933 citations
A Human Histocompatibility Leukocyte Antigen (HLA)-G–specific Receptor Expressed on All Natural Killer Cells
1999 • 711 citations
Cancer principles and practice of oncology
1997 • 659 citations
Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.
1986 • 547 citations
Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes.
1986 • 531 citations
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules.
1998 • 498 citations
Cutting Edge: Soluble HLA-G1 Triggers CD95/CD95 Ligand-Mediated Apoptosis in Activated CD8+ Cells by Interacting with CD8
2000 • 465 citations
Antigen-processing machinery breakdown and tumor growth
2000 • 444 citations
Cutting Edge: Human Myelomonocytic Cells Express an Inhibitory Receptor for Classical and Nonclassical MHC Class I Molecules
1998 • 430 citations
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
1999 • 409 citations
Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis.
1998 • 398 citations
The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells
1999 • 355 citations
A Functional Role of HLA-G Expression in Human Gliomas: An Alternative Strategy of Immune Escape
2002 • 336 citations
Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.
1982 • 327 citations
Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells
2000 • 307 citations
HLA-G expression in early embryos is a fundamental prerequisite for the obtainment of pregnancy
2002 • 300 citations
Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells
1999 • 252 citations
Down-Regulation of HLA Class I Antigen-Processing Molecules in Malignant Melanoma
1999 • 249 citations
Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-gamma.
1996 • 234 citations
A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by geneMAGE-3
2001 • 222 citations
Activated Leukocyte Cell Adhesion Molecule/CD166, a Marker of Tumor Progression in Primary Malignant Melanoma of the Skin
2000 • 208 citations
Association of soluble HLA‐G plasma levels with HLA‐G alleles
2001 • 205 citations
Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 Production
2001 • 205 citations
HLA‐G has a concentration‐dependent effect on the generation of an allo‐CTL response
2000 • 200 citations
A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
1999 • 191 citations
IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism
2002 • 184 citations
Monocytes and T lymphocytes in HIV-1-positive patients express HLA-G molecule
2002 • 182 citations
Specific activation of the non‐classical class I histocompatibility HLA‐G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
2001 • 179 citations
The functionality of HLA‐G is emerging
1999 • 177 citations
Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapy
2001 • 165 citations
Modulation of HLA-G Antigens Expression by Human Cytomegalovirus: Specific Induction in Activated Macrophages Harboring Human Cytomegalovirus Infection
2000 • 161 citations
Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma.
2001 • 160 citations
HLA-G Isoforms Produced by Placental Cytotrophoblasts and Found in Amniotic Fluid Are Due to Unusual Glycosylation
1998 • 158 citations
HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas
2002 • 158 citations
p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily
1998 • 155 citations
Comparison of HMB-45 Monoclonal Antibody and S-100 Protein in the Immunohistochemical Diagnosis of Melanoma
1988 • 154 citations
Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
1984 • 149 citations
Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture
2001 • 147 citations
MATRIX METALLOPROTEINASE-2 (72 kD TYPE IV COLLAGENASE) EXPRESSION OCCURS IN THE EARLY STAGE OF HUMAN MELANOCYTIC TUMOUR PROGRESSION AND MAY HAVE PROGNOSTIC VALUE
1996 • 146 citations
Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies.
1999 • 146 citations
IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism
2002 • 139 citations
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression.
1994 • 111 citations
MHC antigens in human melanomas.
1991 • 111 citations
Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8+ Fas (CD95)+ T lymphocytes
2000 • 109 citations
Paired inhibitory and triggering NK cell receptors for HLA class I molecules
2000 • 103 citations
Presence of HLA‐G‐Expressing Cells Modulates the Ability of Peripheral Blood Mononuclear Cells to Release Cytokines
1997 • 91 citations
Modulation of HLA-G expression in human thymic and amniotic epithelial cells
2000 • 84 citations
Population genetic studies of HLA-G: allele frequencies and linkage disequilibrium with HLA-A
1996 • 80 citations
Soluble HLA-G in Human Placentas: Synthesis in Trophoblasts and Interferon-γ-Activated Macrophages But Not Placental Fibroblasts
1998 • 75 citations
Association between HLA phenotype and HLA concentration in plasma or platelets
1988 • 75 citations
New perspectives on immunobiology and immunotherapy of melanoma
1999 • 65 citations
Immunocytochemical Detection of MART-1 in Fresh and Paraffin-Embedded Malignant Melanomas
1997 • 56 citations
Quantification of soluble HLA class I gene products by an enzyme linked immunosorbent assay
1989 • 55 citations
Evaluation of two sources of soluble HL‐A antigens: platelets and serum
1974 • 53 citations
HLA‐G: expression in human keratinocytes in vitro and in human skin in vivo
1994 • 51 citations
Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions
1990 • 41 citations
Aberrant expression of HLA-G antigen in interferon gamma-stimulated acute myelogenous leukaemia
2000 • 39 citations
Immune escape mechanisms in malignant melanoma.
1999 • 37 citations
Combination Gene Therapy with CD86 and the MHC Class II Transactivator in the Control of Lung Tumor Growth
1999 • 35 citations
Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization
2000 • 32 citations
ASSOCIATION OF SERUM CONCENTRATIONS OF SOLUBLE CLASS I HLA WITH HLA ALLOTYPES
1996 • 28 citations
Soluble HLA class I and class II in Japanese
1994 • 19 citations
Aberrant expression of HLA‐G antigen in interferon γ‐stimulated acute myelogenous leukaemia
2000 • 6 citations